Loperamide mobilizes intracellular Ca2+ stores in insulin-secreting HIT-T15 cells

An inhibitor-mediated beta-cell dedifferentiation model reveals distinct roles for FoxO1 in glucagon repression and insulin maturation

OBJECTIVE

The loss of forkhead box protein O1 (FoxO1) signaling in response to metabolic stress contributes to the etiology of type II diabetes, causing the dedifferentiation of pancreatic beta cells to a cell type reminiscent of endocrine progenitors. Lack of methods to easily model this process in vitro, however, have hindered progress into the identification of key downstream targets and potential inhibitors. We therefore aimed to establish such an in vitro cellular dedifferentiation model and apply it to identify novel agents involved in the maintenance of beta-cell identity.

METHODS

The murine beta-cell line, Min6, was used for primary experiments and high-content screening. Screens encompassed a library of small-molecule drugs representing the chemical and target space of all FDA-approved small molecules with an automated immunofluorescence readout. Validation experiments were performed in a murine alpha-cell line as well as in primary murine and human diabetic islets. Developmental effects were studied in zebrafish and C. elegans models, while diabetic db/db mouse models were used to elucidate global glucose metabolism outcomes.

RESULTS

We show that short-term pharmacological FoxO1 inhibition can model beta-cell dedifferentiation by downregulating beta-cell-specific transcription factors, resulting in the aberrant expression of progenitor genes and the alpha-cell marker glucagon. From a high-content screen, we identified loperamide as a small molecule that can prevent FoxO inhibitor-induced glucagon expression and further stimulate insulin protein processing and secretion by altering calcium levels, intracellular pH, and FoxO1 localization.

CONCLUSIONS

Our study provides novel models, molecular targets, and drug candidates for studying and preventing beta-cell dedifferentiation.

Antimicrobial and immunomodulatory activity induced by loperamide in mycobacterial infections

•

Loperamide modulates macrophages immune responses towards mycobacteria.

•

Loperamide is an immunoregulator of inflammation during mycobacterial infection.

•

Loperamide induces immunomodulatory responses and bactericidal mechanisms.

•

The activation of opioid receptors by loperamide is involved in its immunomodulatory activity.

Intrasperm Ca2+ modulation and human ejaculated sperm viability: influence of miconazole, clotrimazole and loperamide

Elevation of intrasperm Ca2+ is reported to influence viability of ejaculated spermatozoa. Human spermatozoa possess inositol triphosphate (IP3)-sensitive Ca2+ stores, which can be targeted for increasing intrasperm Ca2+ level. The influence of agents affecting Ca2+ homeostasis has been investigated. Miconazole nitrate, clotrimazole and loperamide hydrochloride produced a dose- and time-dependent decrease in viability, each requiring respectively 0.5, 1.0 and 1.0 mM for producing death of all sperm cells immediately upon addition to ejaculated human semen samples. The reduction in sperm viability was accompanied by elevation of intrasperm Ca2+ and was not affected by presence or absence of extracellular Ca2+. Significantly (P < 0.05) less time was required for producing complete loss of sperm viability and increasing intrasperm Ca2+ when any of these drugs was added to sperm cells previously treated with selected agents affecting Ca2+ homeostasis. This enhanced spermicidal activity of miconazole, clotrimazole and loperamide appeared to be due to further mobilization of Ca2+ from partially depleted intrasperm Ca2+ stores. Synergism of spermicidal activity and intrasperm Ca2+ elevation by miconazole or clotrimazole was observed when Ca2+ efflux from sperm cells was simultaneously inhibited by 2′,4′-dichlorobenzamil hydrochloride, a Na+-Ca2+ exchange inhibitor. The spermicidal activity of miconazole, clotrimazole or loperamide due to elevation of intrasperm Ca2+ and its synergism, therefore, has great potential for exploitation of these drugs as contact spermicides.